StageZero Life Sciences Ltd. — Regulatory Filings 2021

Apr 5, 2021

Note: [01 Mar 2017] – The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative.

FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE

MANAGEMENT CERTIFICATION

==> picture [487 x 532] intentionally omitted <==

----- Start of picture text -----

James Howard-Tripp
I, ____ , an officer of the reporting issuer noted below have examined this
Form 13-501F1 (the Form ) being submitted hereunder to the Alberta Securities Commission and
certify that to my knowledge, having exercised reasonable diligence, the information provided in
the Form is complete and accurate.
April 1, 2021
____ ____
Name: Date: James Howard-Tripp
Title: Chairman and Chief Executive Officer
StageZero Life Sciences , Ltd.
Reporting Issuer Name:
December 31, 2020
End date of previous financial year:
Type of Reporting Issuer: [ ] Class 1 reporting [ ] Class 3B reporting
issuer issuer
Toronto Stock Exchange
Highest Trading Marketplace:
Market value of listed or quoted equity securities:
SZLS
Equity Symbol
01/01/2020 31/03/2020
1st Specified Trading Period (dd/mm/yy) __ to _____
Closing price of the security in the class or series on the
last trading day of the specified trading period in which
0.32
such security was listed or quoted on the highest trading $ ____
marketplace (i)
----- End of picture text -----

Number of securities in the class or series of such security outstanding at the end of the last trading day of	Number of securities in the class or series of such security outstanding at the end of the last trading day of	______ 38,184,335
the specified trading period		(ii)
	(i) x (ii)	$ ____ 12,218,987.16
Market value of class or series		(A)
	30/06/2020 01/04/2020
2nd Specified Trading Period(dd/mm/yy)	___ to __
Closing price of the security in the class or series on the
last trading day of the specified trading period in which such security was listed or quoted on the highest trading		$ ____ 0.48
marketplace		(iii)
Number of securities in the class or series of such		48,940,132
security outstanding at the end of the last trading day of		____
the specified trading period		(iv)
	(iii) x (iv)	$ ____ 23,491,263.36
Market value of class or series		(B)
	30/09/2020 01/07/2020
3rd Specified Trading Period(dd/mm/yy)	___ to __
Closing price of the security in the class or series on the
last trading day of the specified trading period in which		0.82
such security was listed or quoted on the highest trading		$ ____
marketplace		(v)
Number of securities in the class or series of such security outstanding at the end of the last trading day of		____ 50,213,306
the specified trading period		(vi)
	(v) x (vi)	$ ____ 41,174,910.72
Market value of class or series		(C)

	01/10/2020	01/10/2020	31/12/2020
4th Specified Trading Period(dd/mm/yy)	___ to __
Closing price of the security in the class or series on the
last trading day of the specified trading period in which			0.75
such security was listed or quoted on the highest trading		$ ____
marketplace		(vii)
Number of securities in the class or series of such			60,716,595
security outstanding at the end of the last trading day of		____
the specified trading period		(viii)
			45,537,446.06
	(vii) x (viii)	$ ____
Market value of class or series		(D)
		N/A	N/A
5th Specified Trading Period(dd/mm/yy)	___ to __
Closing price of the security in the class or series on the
last trading day of the specified trading period in which
such security was listed or quoted on the highest trading		$ ____
marketplace		(ix)
Number of securities in the class or series of such
security outstanding at the end of the last trading day of		____
the specified trading period		(x)
	(ix) x (x)	$ ____
Market value of class or series		(E)
Average Market Value of Class or Series(Calculate
the simple average of the market value of the class or			30,605,651.83
series of security for each applicable specified trading		$ ____
period (i.e. A through E above))		(1)

(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year)

Fair value of outstanding debt securities:
(Provide details of how value was determined)		$ ____
		(2)
		30,605,651.83
Capitalization for the previous financial year	(1) + (2)	$ ____
		1,200
Participation Fee		$ ____
Late Fee, if applicable		$ ____
		1,200
Total Fee Payable		$ ____
(Participation Fee plus Late Fee)